Priority,Rule
Relevance,All abstracts that have client provided keywords
High,"Phase 2 data, Phase 3 data (including meta-analyses), real-world data (including PROs and registry data), Phosphate binders/phosphate lowering treatment"
Internal,Ardelyx sponsored abstracts
Medium,"Phase 1 data, retrospective analyses, prognostic studies, trial designs, preclinical studies; studies with trial outcomes and endpoints; other general studies"
Low,All abstracts that only have mention of an indication and does not include any other data
